STAAR Surgical Company said it has sold more than 4 million Implantable Collamer Lenses (ICLs) worldwide. The company reported it surpassed 1 million ICLs sold in 2019, 2 million in 2022, and 3 million in 2024. STAAR added that the first ICL was implanted in 1993 and that it has sold more than 4 million ICLs in over 85 countries.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20260225087038) on February 25, 2026, and is solely responsible for the information contained therein.